Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer; PrTK03

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitlePhase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer; PrTK03
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsWilliam Jones